Search
Oncology Institute Inc
TOIAdd to Watchlist
5.130USD
0.0000.00%
Close 08-03 16:00（ET）
652.26MMarket Cap
LossP/E TTM
Oncology Institute Inc (TOI) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Oncology Institute Inc in the past month.
Buy
1 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
9.000USD+31.96%
TOI Analyst Recommendation Trends
In the current month, TOI has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TOI average Analyst price target in the last month is 9.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
4
4
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
4
4
4
4
4
4
TOI Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
4
0
0
29
HCA Healthcare Inc
HCA
5
9
11
1
0
26
Teladoc Health Inc
TDOC
2
4
19
0
0
25
Natera Inc
NTRA
10
11
3
0
0
24
Tenet Healthcare Corp
THC
5
14
4
0
0
23
Universal Health Services Inc
UHS
2
4
15
1
0
22
Labcorp Holdings Inc
LH
7
9
4
0
0
20
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Privia Health Group Inc
PRVA
6
12
1
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Financial Forecasting
Based on analysts' estimates, TOI EPS is projected to reach -0.064 in FY2026Q2, following reported EPS of -0.021 in FY2026Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q3
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
Forecast
-0.11
-0.09
-0.08
-0.06
-0.05
Actual
-0.14
-0.06
-0.02
--
--
Surprise
-24.65%
+29.68%
+73.46%
--
--
FAQs
What is Oncology Institute Inc's expected revenue for the next quarter?
Oncology Institute Inc's expected revenue is 155.19M.
What is Oncology Institute Inc's price target?
Analysts forecast that Oncology Institute Inc's price target is USD 6.50, with the highest forecast at USD 8.00 and the lowest forecast at USD 5.00.
How have Oncology Institute IncTOI's recent earnings per share performed?
The market expectation was USD -0.02, while Oncology Institute IncTOI's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for Oncology Institute Inc?
Based on the ratings of Oncology Institute Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.